The Enabling Precision Health and Medicine Bass Connections team is gearing up for its second year, working to further develop and expand infrastructure for the WearDuke Initiative.
Faculty member Christopher Woods is a principal investigator in new DARPA project.
Bass Connections is currently offering several opportunities for Duke faculty.
On August 23, Lori Orlando, M.D., MHS, added another title to her name: Master of Management in Clinical Informatics.
CAGPM faculty members Geoff Ginsburg, Lori Orlando and Rebekah Wu co-authored three papers published in The Lancet.
Brotman Baty Institute (BBI) welcomed several world leaders in genomics and precision medicine to their Scientific Advisory Board, including director Geoff Ginsburg, M.D., Ph.D.
The Enabling Precision Health and Medicine Bass Connections team, led by Susanne Haga has been renewed for the 2019-2020 school year.
A new Bass Connections project, the Smart Toilet: A disruptive technology to improve health and wellness, led by Geoff Ginsburg, has been funded for the 2019-2020 school year.
Ephraim Tsalik is one of five finalists for the Antimicrobial Resistance Diagnostic Challenge through NIH. He will receive a grant to further develop his prototype and supply it for testing to two CLIA-certified independent laboratories.
Micah McClain received a 4-year Merit Award from the VA to explore the host genomic response to rickettsial infections in human patients and develop novel PCR-based tests that are capable of accurately diagnosing Spotted Fever Group rickettsii and Scrub typhus infections, which will allow for better therapeutic decision making.
CAGPM faculty published a paper in The Lancet discussing family health history and how it is underused for actionable risk assessment in patients.
CAGPM faculty and staff members validate a microarray-derived host response signature and explore performance in microbiology-negative and coinfection cases.
Geoff Ginsburg and team review the major technologies used in genomic medicine, discuss approaches to interpret genomic sequence variants, identify publicly available tools for genomic test interpretation, and address barriers to using genomic information in routine practice.
In a new review, Susanne Haga provides background on the use of PGx testing in children as well as mothers and discusses the challenges, benefits, and the ethical, legal and social implications of providing PGx testing to children.
Susanne Haga, Rachel Myers and Lori Orlando assessed young adults' attitudes and knowledge about FHH to understand the barriers to FHH-based risk assessment in young adults. The team also developed and evaluated educational resources designed specifically for young adults.
Orlando was co-author of a paper focusing on the international efforts to build evidence for the optimal return of disease risk genetic variants and use of this data within routine clinical care.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.